Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a
leading specialty insurance provider, today announced financial
results for the first quarter of 2024.
David Clare, President and CEO of Trisura,
stated, “Trisura demonstrated strong performance in the quarter
with Operating net income of $33.2 million, or $0.68 per share,
driven by continued growth, profitable underwriting and higher
investment income.
Continued expansion of market share and
distribution partners drove insurance revenue growth of 16.5%. In
Canada, disciplined underwriting resulted in a Combined ratio of
81.8%, while in US Fronting continued growth and an improved loss
ratio resulted in a strong insurance service result and improved
fronting operational ratio.
Net investment income grew 66.3% in the quarter,
reaching $16.8 million through higher yields and an increased size
of the investment portfolio.
Growth, strong earnings, and gains on the
investment portfolio lifted book value to over $662 million. In the
quarter, we closed the acquisition of our Treasury-listed surety
company and look forward to expanding our US surety presence in the
coming years. With a larger capital base, increased financial
flexibility and ample opportunities to grow, we are optimistic for
the years ahead.”
Financial Highlights
- Insurance
revenue growth of 16.5% compared to Q1 2023 demonstrated continued
momentum across the organization.
- Net income of
$36.4 million in the quarter was higher than Q1 2023 as a result of
growth in the business, improved profitability in US Fronting,
unrealized gains in the investment portfolio and higher net
investment income. Operating net income(1) of $33.2 million in the
quarter increased 16.0% compared to Q1 2023, driven by growth in
the business, profitable underwriting and higher net investment
income.
- EPS of $0.75 in
Q1 2024 was greater than Q1 2023. Operating EPS(2) of $0.68 for the
quarter increased by 11.5%.
- Book value per
share(3) of $13.89 increased 24.6% from March 31, 2023, primarily
the result of earnings in the Canadian operations, higher Net
investment income and the equity raise in Q3 2023.
- ROE(3) was 15.3%
for the period ended Q1 2024 demonstrating an increase compared to
recent quarters and a return to our mid-teens target despite the
impact of the run-off program in 2023. Operating ROE(4) of 20.0%
was comparable to Q1 2023 and benefitted from growth, as well as
higher Net investment income.
Amounts in C$ millions |
Q1 2024 |
Q1 2023 |
Variance |
Insurance revenue |
744.3 |
|
639.1 |
|
16.5 |
% |
Net income |
36.4 |
|
14.0 |
|
160.7 |
% |
Operating net income(1) |
33.2 |
|
28.6 |
|
16.0 |
% |
EPS – diluted, $ |
0.75 |
|
0.30 |
|
150.0 |
% |
Operating EPS – diluted, $(2) |
0.68 |
|
0.61 |
|
11.5 |
% |
Book value per share, $(3) |
13.89 |
|
11.15 |
|
24.6 |
% |
Debt-to-Capital ratio(3) |
10.2 |
% |
12.8 |
% |
(2.6pts |
) |
ROE(3) |
15.3 |
% |
4.1 |
% |
11.2pts |
|
Operating ROE(4) |
20.0 |
% |
20.6 |
% |
(0.6pts |
) |
Combined ratio – Canada |
81.8 |
% |
80.7 |
% |
1.1pts |
|
Fronting operational ratio excluding certain non-recurring items –
US(5) |
84.8 |
% |
86.0 |
% |
(1.2pts |
) |
Insurance Operations
- Insurance
revenue in Canada of $221.9 million in the quarter increased by
23.4% compared to Q1 2023, reflecting increased market share,
expansion of distribution relationships, expanding fronting and
growth of US Surety. Strong underwriting contributed to a Combined
ratio of 81.8%, a ROE of 28.8% and Operating ROE of 28.1% in Q1
2024.
- Insurance
revenue in the US of $522.4 million in the quarter increased by
13.7%, compared to Q1 2023, reflecting favourable market conditions
and maturation of existing programs. Fee income(6) of $22.1 million
in the quarter increased by 23.0% compared to Q1 2023. Net income
of $12.5 million and operating net income of $13.4 million in the
quarter was driven by strong underwriting performance and increased
investment income, which supported a 14.3% Operating ROE.
Capital
- The Minimum
Capital Test ratio(7) of our regulated Canadian subsidiary was 259%
as at March 31, 2024 (251% as at December 31, 2023), which
comfortably exceeded regulatory requirements(8) of 150%.
- As at December
31, 2023, the Risk-Based Capital of the regulated insurance
companies of Trisura US were in excess of the various company
action levels of the states in which they are licensed.
- Consolidated
debt-to-capital ratio of 10.2% as at March 31, 2024 is below our
long-term target of 20.0%.
Investments
- Net investment
income rose 66.3% in the quarter compared to Q1 2023. The portfolio
benefited from higher risk-adjusted yields, increased capital
generated from strong operational performance and recent equity
raises.
Corporate Development
- Closed the acquisition of First Founders Assurance Company, a
US Treasury listed surety company.
Governance
- Appointed Lilia
Sham to the Company’s Board of Directors.
Earnings Conference Call
Trisura will host its First Quarter Earnings
Conference Call to review financial results at 9:00a.m. ET on
Friday, May 3rd, 2024.
To listen to the call via live audio webcast,
please follow the link below:
https://edge.media-server.com/mmc/p/w5mnnx7z
A replay of the call will be available through the link
above.
Investor Day
Immediately following the Company’s Annual
General Meeting, which will be held on Monday, June 3rd, 2024 at
10:00am (Eastern Time) at the North Tower, 200 Bay Street, Suite
1600 in Toronto, Trisura will host an investor presentation to
discuss long-term strategy and market conditions.
To register for the Investor Day, or to access the live audio
webcast, please follow the link below:
https://reg.lumiengage.com/trisura-2024
About Trisura Group
Trisura Group Ltd. is a specialty insurance
provider operating in the Surety, Risk Solutions, Corporate
Insurance, and Fronting business lines of the market. Trisura has
investments in wholly owned subsidiaries through which it conducts
insurance and reinsurance operations. Those operations are
primarily in Canada and the United States. Trisura Group Ltd. Is
listed on the Toronto Stock Exchange under the symbol “TSU”.
Further information is available at
https://www.trisura.com. Important information may be disseminated
exclusively via the website; investors should consult the site to
access this information. Details regarding the operations of
Trisura Group Ltd. are also set forth in regulatory filings. A copy
of the filings may be obtained on Trisura Group’s SEDAR+ profile at
www.sedarplus.com.
For more information, please contact:Name: Bryan
SinclairTel: 416-607-2135Email: bryan.sinclair@trisura.com
Trisura Group Ltd.Condensed Interim Consolidated
Statements of Financial PositionAs at March 31, 2024 and
December 31, 2023(in thousands of Canadian
dollars, except as otherwise noted) |
As at |
March 31, 2024 |
December 31, 2023 |
Cash and cash equivalents |
636,186 |
604,016 |
Investments |
1,056,639 |
890,157 |
Other assets |
33,678 |
53,712 |
Reinsurance contract assets |
1,947,341 |
2,003,589 |
Capital assets and intangible assets |
28,053 |
16,657 |
Deferred tax assets |
34,890 |
16,314 |
Total assets |
3,736,787 |
3,584,445 |
Insurance contract liabilities |
2,871,676 |
2,769,951 |
Other liabilities |
127,897 |
120,065 |
Loan payable |
75,000 |
75,000 |
Total liabilities |
3,074,573 |
2,965,016 |
Shareholders' equity |
662,214 |
619,429 |
Total liabilities and shareholders' equity |
3,736,787 |
3,584,445 |
Trisura Group Ltd.Condensed Interim Consolidated
Statements of Comprehensive IncomeFor the three months
ended March 31(in thousands of Canadian dollars,
except as otherwise noted) |
|
Q1 2024 |
Q1 2023 |
Insurance revenue |
744,266 |
|
639,100 |
|
Insurance service expenses |
(580,940 |
) |
(500,443 |
) |
Net expense from reinsurance contracts assets |
(127,878 |
) |
(121,942 |
) |
Insurance service result |
35,448 |
|
16,715 |
|
Net investment income |
16,753 |
|
10,071 |
|
Net gains (losses) |
12,276 |
|
(2,215 |
) |
Net credit impairment losses |
(1,830 |
) |
(149 |
) |
Total investment income |
27,199 |
|
7,707 |
|
Finance expenses from insurance contracts |
(36,658 |
) |
(36,628 |
) |
Finance income from reinsurance contracts |
32,800 |
|
31,902 |
|
Net insurance finance (expenses) income |
(3,858 |
) |
(4,726 |
) |
Net financial result |
23,341 |
|
2,981 |
|
Net insurance and financial result |
58,789 |
|
19,696 |
|
Other income |
5,345 |
|
5,178 |
|
Other operating expenses |
(15,012 |
) |
(5,432 |
) |
Other finance costs |
(614 |
) |
(600 |
) |
Income before income taxes |
48,508 |
|
18,842 |
|
Income tax expense |
(12,075 |
) |
(4,866 |
) |
Net income |
36,433 |
|
13,976 |
|
Operating net income |
33,188 |
|
28,613 |
|
Other comprehensive income |
8,939 |
|
5,921 |
|
Comprehensive income |
45,372 |
|
19,897 |
|
Trisura Group Ltd.Condensed Interim Consolidated
Statements of Cash FlowsFor the three months ended March
31(in thousands of Canadian dollars, except as
otherwise noted) |
|
Q1 2024 |
Q1 2023 |
Net income |
36,433 |
|
13,976 |
|
Non-cash items |
(6,384 |
) |
5,232 |
|
Change in working capital |
160,070 |
|
(1,046 |
) |
Realized losses |
330 |
|
245 |
|
Income taxes paid |
(4,056 |
) |
(3,837 |
) |
Interest paid |
(115 |
) |
(127 |
) |
Net cash from operating activities |
186,278 |
|
14,443 |
|
Proceeds on disposal of investments |
38,368 |
|
31,601 |
|
Purchases of investments |
(179,636 |
) |
(79,987 |
) |
Acquisition of subsidiary |
(15,015 |
) |
- |
|
Net purchases of capital and intangible assets |
(532 |
) |
(177 |
) |
Net cash used in investing activities |
(156,815 |
) |
(48,563 |
) |
Shares issued |
1,335 |
|
711 |
|
Shares purchased under Restricted Share Units plan |
(3,076 |
) |
(869 |
) |
Lease payments |
(586 |
) |
(512 |
) |
Net cash (used in) from financing activities |
(2,327 |
) |
(670 |
) |
Net increase in cash and cash equivalents, during the
period |
27,136 |
|
(34,790 |
) |
Cash and cash equivalents, beginning of period |
604,016 |
|
406,368 |
|
Currency translation |
5,034 |
|
(3,368 |
) |
Cash and cash equivalents, end of period |
636,186 |
|
368,210 |
|
Non-IFRS Financial Measures
Table 1 – Reconciliation of reported Net income to
Operating net
income(1):
reflect Net income, adjusted for certain items to normalize
earnings to core operations in order to reflect our North American
specialty operations.
|
Q1 2024 |
Q1 2023 |
Net income |
36,433 |
|
13,976 |
|
Adjustments: |
|
|
Non-recurring items |
3,714 |
|
14,691 |
|
Impact of share based compensation |
2,923 |
|
(3,370 |
) |
Impact of movement in yield curve within Finance income from
insurance and reinsurance contracts |
(436 |
) |
4,726 |
|
Net (gains) losses |
(12,276 |
) |
2,215 |
|
Net credit impairment losses |
1,830 |
|
149 |
|
Tax impact of above items |
1,000 |
|
(3,774 |
) |
Operating net income |
33,188 |
|
28,613 |
|
Table 2 –
ROE(3) and
Operating ROE(4): a measure of the
Company’s use of equity.
|
Q1 2024 |
Q1 2023 |
LTM net income |
89,398 |
|
18,433 |
|
LTM average equity |
583,798 |
|
449,417 |
|
ROE |
15.3 |
% |
4.1 |
% |
Operating LTM net income(4) |
116,819 |
|
92,666 |
|
LTM average equity |
583,798 |
|
449,417 |
|
Operating LTM ROE |
20.0 |
% |
20.6 |
% |
Table 3 – Reconciliation of Average
equity(9) to LTM
average equity: LTM average equity is used in calculating
Operating ROE.
|
Q1 2024 |
Q1 2023 |
Average equity |
587,336 |
|
439,502 |
Adjustments: days in quarter proration |
(3,538 |
) |
9,915 |
LTM average equity |
583,798 |
|
449,417 |
Footnotes
(1) See section on Non-IFRS financial measures
table 10.2.1 in Q1 2024 MD&A for details on composition.
Operating net income is a non-IFRS financial measure. Non-IFRS
financial measures are not standardized financial measures under
the financial reporting framework used to prepare the financial
statements of the Company to which the measure relates and might
not be comparable to similar financial measures disclosed by other
companies. Details and an explanation of how it provides useful
information to an investor can be found in the Q1 2024 MD&A,
Section 10, Operating Metrics table.
(2) This is a non-IFRS ratio, see table 10.2 in
Q1 2024 MD&A for details on composition, as well as each
non-IFRS financial measure used as a component of the ratio, and an
explanation of how it provides useful information to an investor.
Non-IFRS ratios are not standardized under the financial reporting
framework used to prepare the financial statements of the Company
to which the ratio relates and might not be comparable to similar
ratios disclosed by other companies. To access MD&A, see
Trisura’s website or SEDAR+ at www.sedarplus.ca.
(3) This is a supplementary financial measure.
Refer to Q1 2024 MD&A, Section 10, Operating Metrics table for
its composition.
(4) This is a non-IFRS ratio. See table 10.4 in
Q1 2024 MD&A for details on composition, as well as each
non-IFRS financial measure used as a component of ratio, and an
explanation of how it provides useful information to an
investor.
(5) This is a non-IFRS financial measure.
Adjusted figures exclude the impacts from write down of reinsurance
recoverables, and the run-off program.
(6) This is a non-IFRS financial measure. See
table 10.5.4 in Q1 2024 MDA for details on composition.
(7) This measure is calculated in accordance
with the Office of the Superintendent of Financial Institutions
Canada’s (OSFI’s) Guideline A, Minimum Capital Test.
(8) This target is in accordance with OSFI’s
Guideline A-4, Regulatory Capital and Internal Capital Targets.
(9) Average equity is calculated as the sum of
opening equity and closing equity over the last twelve months,
divided by two.
Cautionary Statement Regarding Forward-Looking
Statements and Information
Note: This news release contains
“forward-looking information” within the meaning of Canadian
provincial securities laws and “forward-looking statements” within
the meaning of applicable Canadian securities legislation.
Forward-looking statements include statements that are predictive
in nature, depend upon or refer to future events or conditions,
include statements regarding operations, business, financial
condition, expected financial results, performance, prospects,
opportunities, priorities, targets, goals, ongoing objectives,
strategies and outlook of our Company and its subsidiaries, as well
as the outlook for North American and international economies for
the current fiscal year and subsequent periods, and include words
such as “expects,” “likely,” “anticipates,” “plans,” “believes,”
“estimates,” “seeks,” “intends,” “targets,” “projects,”
“forecasts”, “potential” or negative versions thereof and other
similar expressions, or future or conditional verbs such as “may,”
“will,” “should,” “would” and “could”.
Although we believe that our anticipated future
results, performance or achievements expressed or implied by the
forward-looking statements and information are based upon
reasonable assumptions and expectations, the reader should not
place undue reliance on forward-looking statements and information
because they involve known and unknown risks, uncertainties and
other factors, many of which are beyond our control, which may
cause the actual results, performance or achievements of our
Company to differ materially from anticipated future results,
performance or achievement expressed or implied by such
forward-looking statements and information.
Factors that could cause actual results to
differ materially from those contemplated or implied by
forward-looking statements include, but are not limited to: the
impact or unanticipated impact of general economic, political and
market factors in the countries in which we do business; the
behaviour of financial markets, including fluctuations in interest
and foreign exchange rates; global equity and capital markets and
the availability of equity and debt financing and refinancing
within these markets; insurance risks including pricing risk,
concentration risk and exposure to large losses, and risks
associated with estimates of loss reserves; strategic actions
including dispositions; the ability to complete and effectively
integrate acquisitions into existing operations and the ability to
attain expected benefits; changes in accounting policies and
methods used to report financial condition (including uncertainties
associated with critical accounting assumptions and estimates); the
ability to appropriately manage human capital; the effect of
applying future accounting changes; business competition;
operational and reputational risks; technological change; changes
in government regulation and legislation within the countries in
which we operate; governmental investigations; litigation; changes
in tax laws; changes in capital requirements; changes in
reinsurance arrangements and availability and cost of reinsurance;
ability to collect amounts owed; catastrophic events, such as
earthquakes, hurricanes or pandemics; the possible impact of
international conflicts and other developments including terrorist
acts and cyberterrorism; risks associated with reliance on
distribution partners, capacity providers and program
administrators; third party risks; risk that models used to manage
the business do not function as expected; climate change risk; risk
of economic downturn; risk of inflation; risks relating to
cyber-security; risks relating to credit ratings; and other risks
and factors detailed from time to time in our documents filed with
securities regulators in Canada.
We caution that the foregoing list of important
factors that may affect future results is not exhaustive. When
relying on our forward-looking statements and information,
investors and others should carefully consider the foregoing
factors and other uncertainties and potential events. Except as
required by law, our Company undertakes no obligation to publicly
update or revise any forward-looking statements or information,
whether written or oral, that may be as a result of new
information, future events or otherwise.
Cautionary Non-IFRS and Other Financial
Measures
Reported results conform to generally accepted
accounting principles (GAAP), in accordance with IFRS. In addition
to reported results, our Company also presents certain financial
measures, including non-IFRS financial measures that are
historical, non-IFRS ratios, and supplementary financial measures,
to assess results. Non-IFRS financial measures, such as operating
net income, are utilized to assess the Company’s overall
performance. To arrive at operating results, our Company adjusts
for certain items to normalize earnings to core operations, in
order to reflect our North American specialty operations. Non-IFRS
ratios include a non-IFRS financial measure as one or more of its
components. Examples of non-IFRS ratios include operating diluted
earnings per share and operating ROE. The Company believes that
non-IFRS financial measures and non-IFRS ratios provide the reader
with an enhanced understanding of our results and related trends
and increase transparency and clarity into the core results of the
business. Non-IFRS financial measures and non-IFRS ratios are not
standardized terms under IFRS and, therefore, may not be comparable
to similar terms used by other companies. Supplementary financial
measures depict the Company’s financial performance and position,
and are explained in this document where they first appear, and
incorporates information by reference to our Company’s current
MD&A, for the three months ended March 31, 2024. To access
MD&A, see Trisura’s website or SEDAR+ at www.sedarplus.ca.
These measures are pursuant to National Instrument 52-112 Non-GAAP
and Other Financial Measures Disclosure.
Trisura (TSX:TSU)
過去 株価チャート
から 11 2024 まで 12 2024
Trisura (TSX:TSU)
過去 株価チャート
から 12 2023 まで 12 2024